BOSTON SCIENTIFIC CORP (Form: 8-K, Received: 04/10/2020 09:36:39)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 10, 2020

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		1-11083		04-2695240
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

300 Boston Scientific Way		Marlborough		Massachusetts		01752-1234
(Address of Principal Executive Offices)						(Zip Code)

508 683-4000

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.01 par value per share	BSX	New York Stock Exchange
0.625% Senior Notes due 2027	BSX27	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On April 10, 2020, Boston Scientific Corporation issued a press release announcing that its Annual Meeting of Stockholders, to be held on May 7, 2020 at 8:00 a.m. Eastern Time, will be a virtual-only meeting via live audio webcast. The Company has made this decision to host a virtual-only meeting in direct response to the public health impact of the coronavirus outbreak (COVID-19), and in accordance with orders issued by the Governor of the Commonwealth of Massachusetts limiting public gatherings and to support the health and well-being of our stockholders, employees, directors and other participants. A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.		Description
99.1		Press release of Boston Scientific Corporation, dated April 10, 2020
104		Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	April 10, 2020	BOSTON SCIENTIFIC CORPORATION

		By:	/s/ Vance R. Brown
			Vance R. Brown
			Vice President and Chief Corporate Counsel

Exhibit 99.1

Boston Scientific Announces 2020 Annual Meeting of Stockholders

Will Be Conducted In Virtual Format

MARLBOROUGH, Mass., April 10, 2020 – Boston Scientific Corporation (NYSE: BSX) today announced that its Annual Meeting of Stockholders (the “Annual Meeting”) will be held exclusively in a virtual meeting format at the previously announced date and time of May 7, 2020 at 8:00 a.m. Eastern Time. In response to the public health impact of the coronavirus outbreak (COVID-19), in accordance with orders issued by the Governor of the Commonwealth of Massachusetts limiting public gatherings and to support the health and well-being of our stockholders, employees, directors and other participants, the Annual Meeting will be conducted via live audio webcast. Stockholders will not be able to attend the Annual Meeting in person.

As described in the previously distributed proxy materials for the Annual Meeting, only stockholders at the close of business on March 13, 2020 are entitled to participate in the Annual Meeting. Stockholders will be admitted to the virtual Annual Meeting at https://www.virtualshareholdermeeting.com/BSX2020 by entering the 16-digit control number that can be found on their proxy card, voting instruction form or notice. Stockholders will have the opportunity to vote their shares during the Annual Meeting by following the instructions available on the meeting website during the Annual Meeting. Stockholders will also be provided an opportunity to ask questions at the Annual Meeting using the instructions provided on the meeting website.

The Company encourages eligible stockholders to vote on the proposals prior to the Annual Meeting using the instructions provided in the previously distributed proxy statement. The proxy card included with the proxy materials previously distributed may continue to be used to vote shares in connection with the Annual Meeting.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS:

Media:

Kate Haranis
Media Relations
(508) 683-6585
Kate.Haranis@bsci.com

Susie Lisa, CFA
Investor Relations
(508) 683-5565 (office)
BSXInvestorRelations@bsci.com